GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » Sale Of Business

Femtobiomed (XKRX:327610) Sale Of Business : ₩0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed Sale Of Business?

Femtobiomed's sale of business for the six months ended in Dec. 2023 was ₩0.0 Mil. It means Femtobiomed gained ₩0.0 Mil from selling business. Femtobiomed's sale of business for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0.0 Mil.

Compared with last quarter (₩0.0 Mil in Dec. 2022 ), Femtobiomed gained the same money from selling business in Dec. 2023 (₩0.0 Mil).


Femtobiomed Sale Of Business Historical Data

The historical data trend for Femtobiomed's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed Sale Of Business Chart

Femtobiomed Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial - - - - -

Femtobiomed Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business Get a 7-Day Free Trial - - - - -

Femtobiomed Sale Of Business Calculation

The amount earned to sell business.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Femtobiomed Sale Of Business Related Terms

Thank you for viewing the detailed overview of Femtobiomed's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Femtobiomed Business Description

Traded in Other Exchanges
N/A
Address
17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487
Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed Headlines

No Headlines